• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SenesTech's Evolve® Approved in New Zealand

    2/2/26 8:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials
    Get the next $SNES alert in real time by email

    Supporting New Zealand's Predator Free 2050 Initiative

    Initial Stocking Order Fulfilled

    PHOENIX, Feb. 2, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, is pleased to announce that Evolve® has been approved for use in New Zealand by the Ministry for Primary Industries. SenesTech's exclusive distribution partner, Evicom, has been shipped its initial stocking order.

    SenesTech, Inc. is a pioneer in fertility control solutions for managing rodent populations. (PRNewsfoto/SenesTech, Inc.)

    Rodent overpopulation remains a major ecological and economic challenge in New Zealand, threatening native wildlife, agriculture, and urban environments. Evolve is a revolutionary birth control solution that restricts rodent reproduction at its source, offering a non-lethal, environmentally responsible alternative that seamlessly integrates into existing IPM strategies.

    New Zealand's Predator Free 2050 initiative is one of the most ambitious conservation programs in the world, aiming to eradicate invasive predators such as rats, stoats, and possums to safeguard native species. New Zealand expects to spend over $4.5 billion on this program, explicitly counting on advancements in technology and the development of more efficient and effective eradication methods to accomplish their goals. Evolve represents an ideal partner for this effort, as it reduces rat populations without the collateral damage of poisons, preserving biodiversity and delicate ecosystems in line with New Zealand's conservation goals.

    "We are delivering on our strategy to become the global leader in sustainable fertility control solutions for managing rat populations, while tapping into significant, high-growth markets that are actively seeking sustainable and effective alternatives to traditional rodenticides," said Joel Fruendt, President and CEO of SenesTech. "The Evolve products are aligning with changing regulatory standards and environmental policies. This is especially crucial for New Zealand, where protecting native wildlife is a national priority."

    "We have shipped a container to launch the product in New Zealand, and expect to maintain a regular shipping schedule with Evicom," continued Fruendt.

    About SenesTech, Inc.

    SenesTech is committed to creating healthier environments by sustainably managing animal pest populations through fertility control. The company's groundbreaking products, including Evolve rodent birth control, which integrates seamlessly into pest management programs, significantly enhancing their effectiveness while reducing reliance on traditional poisons. SenesTech's mission is to create cleaner cities, more efficient businesses, and healthier communities with products that are effective and sustainable.

    For more information, visit https://senestech.com.

    Safe Harbor Statement

    This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the potential scale of product deployment, and the effectiveness of Evolve in New Zealand's Predator Free 2050 initiative. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. These include, but are not limited to, the successful commercialization of our products, regulatory approvals, and market acceptance. SenesTech does not undertake any obligation to update forward-looking statements except as required by law.

    Company Contact:

    Tom Chesterman, CFO

    (928) 233-7533

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/senestechs-evolve-approved-in-new-zealand-302675862.html

    SOURCE SenesTech, Inc.

    Get the next $SNES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNES

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SNES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $94,524 worth of shares (48,138 units at $1.96) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/3/26 5:27:37 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    New insider Glenbrook Capital Management claimed ownership of 545,647 shares (SEC Form 3)

    3 - SenesTech, Inc. (0001680378) (Issuer)

    2/2/26 5:22:15 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Director Leach Jacob Steven sold $168 worth of shares (62 units at $2.71), closing all direct ownership in the company (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    11/19/25 7:48:43 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $94,524 worth of shares (48,138 units at $1.96) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/3/26 5:27:37 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SenesTech's Evolve® Approved in New Zealand

    Supporting New Zealand's Predator Free 2050 Initiative Initial Stocking Order Fulfilled PHOENIX, Feb. 2, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, is pleased to announce that Evolve® has been approved for use in New Zealand by the Ministry for Primary Industries. SenesTech's exclusive distribution partner, Evicom, has been shipped its initial stocking order. Rodent overpopulation remains a major ecological and economic challenge in New Zealand, threatening native wildlife, agriculture, and urba

    2/2/26 8:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Expands International Reach with the Addition of the Belize Raptor Center as an Official Distributor of Evolve® Rat Birth Control

    SURPRISE, Ariz., Nov. 11, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the pioneer in fertility control for managing animal pest populations, proudly announces the addition of Sarah Mann and the Belize Raptor Center as the newest international distributor of Evolve® Rat Birth Control. Through the leadership of Sarah Mann with the support of the Pesticides Control Board of Belize, Evolve Rat received approval for import and distribution in Belize, a country whose biodiversity is being threatened by the alarming increase of unregulated rodenticides and the severe ecologic

    11/11/25 9:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by SenesTech Inc.

    SCHEDULE 13G/A - SenesTech, Inc. (0001680378) (Subject)

    2/2/26 5:26:13 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SenesTech Inc. filed SEC Form 8-K: Leadership Update

    8-K/A - SenesTech, Inc. (0001680378) (Filer)

    1/28/26 5:26:33 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Inc. filed SEC Form 8-K: Leadership Update

    8-K - SenesTech, Inc. (0001680378) (Filer)

    1/28/26 4:01:46 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Leadership Updates

    Live Leadership Updates

    View All

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Names Nicole Williams as Chief Revenue Officer

    PHOENIX, Feb. 16, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the appointment of Nicole Williams as Chief Revenue Officer. Ms. Williams was previously Chief Strategy Officer, and this appointment is part of an expansion and restructuring of the sales organization and commercialization efforts. The restructuring of the team comes after yet another quarter and fiscal ye

    2/16/23 9:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces Appointment of Vector and Pest Control Industry Veteran Joel Fruendt as Chief Executive Officer

    PHOENIX, Nov. 14, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the appointment of Joel Fruendt as SenesTech's new Chief Executive Officer, succeeding Ken Siegel. Mr. Siegel, who is expected to retire at the end of the year, will remain as an Executive Director, in a consultative role, through the transition period. This leadership transition is part of SenesTech's ongoing strategic plan to drive the commercialization of ContraPest, its flagship product.

    11/14/22 9:10:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Financials

    Live finance-specific insights

    View All

    SenesTech Reports Third Quarter 2025 Financial Results with Record Revenue and Adjusted EBITDA

    77% Revenue Growth in Evolve® Rodent Birth Control™ Products Strong Cash Balance and Progress Toward Profitability SURPRISE, Ariz., Nov. 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products today announced its financial results for the third quarter ended September 30, 2025. Q3 2025 Financial Highlights Revenues increased by 43% to $690,000, a record for the Company, from $482,000 in Q3 2024.Evolve® Rodent Birth Control product sales

    11/10/25 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025

    Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, Nov. 3, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for pest management, will report third quarter 2025 financial results for the period ended September 30, 2025, after the market close on Monday, November 10, 2025. The Company has scheduled a conference call that same day, Monday, November 10, 2025, at 5:00 p.m. Eastern time, to review the results. Third Quarter 2025 Conference Call Details Date and Time: Monday, Novem

    11/3/25 4:15:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins

    94% Revenue Growth in Evolve™ Rodent Birth Control Products Strong Cash Balance and Sustained Progress Toward Profitability SURPRISE, Ariz., Aug. 7, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the second quarter ended June 30, 2025. Q2 2025 Highlights Revenues increased 36% to $625,000, a record for the Company, from $459,000 in Q2 2024.Evolve Rodent Birth Control products sales grew 94%

    8/7/25 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:12:23 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G filed by SenesTech Inc.

    SC 13G - SenesTech, Inc. (0001680378) (Subject)

    11/12/24 4:30:48 PM ET
    $SNES
    Agricultural Chemicals
    Industrials